Synthetic Derivatives of Natural ent-Kaurane Atractyligenin Disclose Anticancer Properties in Colon Cancer Cells, Triggering Apoptotic Cell Demise

Int J Mol Sci. 2024 Mar 31;25(7):3925. doi: 10.3390/ijms25073925.

Abstract

The antitumor activity of different ent-kaurane diterpenes has been extensively studied. Several investigations have demonstrated the excellent antitumor activity of synthetic derivatives of the diterpene atractyligenin. In this research, a series of new synthetic amides and their 15,19-di-oxo analogues obtained from atractyligenin by modifying the C-2, C-15, and C-19 positions were designed in order to dispose of a set of derivatives with different substitutions at the amidic nitrogen. Using different concentrations of the obtained compounds (10-300 μM) a reduction in cell viability of HCT116 colon cancer cells was observed at 48 h of treatment. All the di-oxidized compounds were more effective than their alcoholic precursors. The di-oxidized compounds had already reduced the viability of two colon cancer cells (HCT116 and Caco-2) at 24 h when used at low doses (2.5-15 μM), while they turned out to be poorly effective in differentiated Caco-2 cells, a model of polarized enterocytes. The data reported here provide evidence that di-oxidized compounds induced apoptotic cell death, as demonstrated by the appearance of condensed and fragmented DNA in treated cells, as well as the activation of caspase-3 and fragmentation of its target PARP-1.

Keywords: Caco-2; HCT116; Poly [ADP-ribose] polymerase 1; apoptotic cell death; atractyligenin derivatives; chromatin fragmentation.

MeSH terms

  • Amides
  • Apoptosis
  • Atractyloside / analogs & derivatives*
  • Caco-2 Cells
  • Colonic Neoplasms* / drug therapy
  • Diterpenes, Kaurane* / pharmacology
  • Humans

Substances

  • atractyligenine
  • Diterpenes, Kaurane
  • Amides
  • Atractyloside